| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-11 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-10 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-10 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-09 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.26 | 1e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.32 | 4e-07 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-06 |